168 related articles for article (PubMed ID: 34156978)
1. MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
Wang WJ; Lai HY; Zhang F; Shen WJ; Chu PY; Liang HY; Liu YB; Wang JM
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156978
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
4. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
[TBL] [Abstract][Full Text] [Related]
5. Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer.
Wang W; Yin X; Li G; Yi J; Wang J
Chin Med J (Engl); 2014; 127(14):2637-42. PubMed ID: 25043081
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer.
Jiang L; Zhang L; Shu Y; Zhang Y; Gao L; Qiu S; Zhang W; Dai W; Chen S; Huang Y; Liu Y
J Biol Chem; 2024 Apr; 300(4):107171. PubMed ID: 38492776
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
Wang FT; Wang H; Wang QW; Pan MS; Li XP; Sun W; Fan YZ
Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
[TBL] [Abstract][Full Text] [Related]
9. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.
Tian L; Lu Y; Yang T; Deng Z; Xu L; Yao W; Ma C; Li X; Zhang J; Liu Y; Wang J
Redox Biol; 2019 Apr; 22():101149. PubMed ID: 30822690
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
Xue Z; Yang B; Xu Q; Zhu X; Qin G
Biochem Biophys Res Commun; 2020 Feb; 522(4):952-959. PubMed ID: 31810606
[TBL] [Abstract][Full Text] [Related]
11. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R
Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder Cancer Cell-Derived Exosome-Mediated Transfer of Leptin Promotes Cell Invasion and Migration by Modulating STAT3-Mediated M2 Macrophage Polarization.
Zhao S; Liu Y; He L; Li Y; Lin K; Kang Q; Liu L; Zou H
Anal Cell Pathol (Amst); 2022; 2022():9994906. PubMed ID: 35111566
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
Ye J; Qi L; Du Z; Yu L; Chen K; Li R; Feng R; Zhai W
Aging (Albany NY); 2021 Feb; 13(4):5607-5620. PubMed ID: 33591948
[TBL] [Abstract][Full Text] [Related]
14. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
Gao H; Xie J; Peng J; Han Y; Jiang Q; Han M; Wang C
Exp Cell Res; 2015 Mar; 332(2):236-46. PubMed ID: 25499970
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
Kitagawa K; Moriya K; Kaji K; Saikawa S; Sato S; Nishimura N; Namisaki T; Akahane T; Mitoro A; Yoshiji H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066548
[TBL] [Abstract][Full Text] [Related]
16. miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
Wang H; Zhan M; Xu SW; Chen W; Long MM; Shi YH; Liu Q; Mohan M; Wang J
Cell Death Dis; 2017 May; 8(5):e2770. PubMed ID: 28492560
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
Wu WD; Hu ZM; Shang MJ; Zhao DJ; Zhang CW; Hong DF; Huang DS
Int J Mol Sci; 2014 Jul; 15(7):12778-90. PubMed ID: 25046749
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
Wang W; Hu Z; Huang Y; Zheng H; Sun Q; Yang Q; Zhang Y; Zhang L; Wang W
Biomed Res Int; 2019; 2019():9205851. PubMed ID: 31019975
[TBL] [Abstract][Full Text] [Related]
19. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Yu Y; Wang J; Xia N; Li B; Jiang X
Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
[TBL] [Abstract][Full Text] [Related]
20. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
